S. Muoio & Co’s Teva Pharmaceuticals TEVA Stock Holding History

S. Muoio & Co’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-29,400	Closed	-$74K	–	120
2015 Q3	$74K	Buy	+29,400	New	+$1.91M	0.04%	103

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

S. Muoio & Co's TEVA Position: Q4 2015 in Review

S. Muoio & Co sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 29,400 shares — an estimated $74K sold.

S. Muoio & Co first reported a position in TEVA in Q3 2015 and held it in 1 quarter. The position peaked at $74K in Q3 2015. 876 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

S. Muoio & Co reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
S. Muoio & Co sold 29,400 Teva Pharmaceuticals shares in Q4 2015, an estimated $74K.
S. Muoio & Co first reported a position in Teva Pharmaceuticals in Q3 2015 and held it in 1 quarter.
S. Muoio & Co's Teva Pharmaceuticals position peaked at $74K in Q3 2015.
876 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on S. Muoio & Co's 13F filing for Q4 2015, filed 12 Feb 2016.